scholarly article | Q13442814 |
P50 | author | James R. Bradford | Q42552817 |
Nicola J Camp | Q87666063 | ||
P2093 | author name string | Henry Brown | |
Simon T Barry | |||
Anne Marie Mazzola | |||
Celina D'Cruz | |||
Armelle Logie | |||
Garry Beran | |||
Joanna Boros | |||
Mark Wappett | |||
Oona Delpuech | |||
Robert McEwen | |||
P2860 | cites work | The CD44+/CD24- phenotype is enriched in basal-like breast tumors | Q21092906 |
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
Ensembl 2014 | Q24567767 | ||
NCBI GEO: archive for functional genomics data sets--update | Q24595691 | ||
Patient-derived tumour xenografts as models for oncology drug development | Q24604068 | ||
Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche | Q24606366 | ||
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation | Q24627354 | ||
Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib | Q27315803 | ||
Lysyl oxidase mediates hypoxic control of metastasis | Q28271667 | ||
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer | Q28275492 | ||
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 | ||
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 | ||
HTSeq--a Python framework to work with high-throughput sequencing data | Q29614489 | ||
Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer. | Q43171997 | ||
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer | Q46085608 | ||
E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling. | Q54380363 | ||
Relation of a Hypoxia Metagene Derived from Head and Neck Cancer to Prognosis of Multiple Cancers | Q58211840 | ||
Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database | Q81336038 | ||
Purity for clarity: the need for purification of tumor cells in DNA microarray studies | Q81471249 | ||
Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients | Q83978512 | ||
STAR: ultrafast universal RNA-seq aligner | Q29615052 | ||
Supervised risk predictor of breast cancer based on intrinsic subtypes | Q29617404 | ||
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies | Q29617680 | ||
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features | Q29620020 | ||
Inferring tumour purity and stromal and immune cell admixture from expression data | Q30674996 | ||
Stromal gene expression predicts clinical outcome in breast cancer | Q33330931 | ||
A flexible R package for nonnegative matrix factorization | Q33624159 | ||
EMT is the dominant program in human colon cancer | Q33798739 | ||
Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. | Q34137672 | ||
Patient-derived xenograft models: an emerging platform for translational cancer research | Q34205518 | ||
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors | Q34296476 | ||
Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium | Q34686883 | ||
β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer | Q34924186 | ||
Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics. | Q34937584 | ||
ToppGene Suite for gene list enrichment analysis and candidate gene prioritization | Q34982758 | ||
Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer. | Q35534811 | ||
GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells | Q35605895 | ||
Tumor intrinsic subtype is reflected in cancer-adjacent tissue. | Q35624103 | ||
Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment | Q35655229 | ||
Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man? | Q35906275 | ||
Xenome--a tool for classifying reads from xenograft samples. | Q36022173 | ||
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer. | Q36142926 | ||
The molecular profile of luminal B breast cancer | Q36196676 | ||
Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients. | Q36245556 | ||
Gene expression changes in a tumor xenograft by a pyrrole-imidazole polyamide | Q36342812 | ||
Molecular characterization of basal-like and non-basal-like triple-negative breast cancer | Q36630430 | ||
Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies | Q36796375 | ||
Origin of the vasculature supporting growth of primary patient tumor xenografts | Q36863454 | ||
ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer. | Q37185320 | ||
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures | Q37281532 | ||
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes. | Q37321751 | ||
The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer | Q37681755 | ||
Stromal contribution to the colorectal cancer transcriptome. | Q38906913 | ||
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype | Q40012189 | ||
Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. | Q40253607 | ||
Identification of DEAD-box RNA helicase 6 (DDX6) as a cellular modulator of vascular endothelial growth factor expression under hypoxia | Q41832579 | ||
P4510 | describes a project that uses | Cytoscape | Q3699942 |
limma | Q112236343 | ||
DESeq2 | Q113018293 | ||
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
transcriptome | Q252857 | ||
biomarker | Q864574 | ||
RNA sequencing | Q2542347 | ||
xenograft | Q64148587 | ||
P304 | page(s) | 20773-20787 | |
P577 | publication date | 2016-03-09 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers | |
P478 | volume | 7 |
Q89047103 | An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors |
Q64922761 | Comprehensive functional profiling of long non-coding RNAs through a novel pan-cancer integration approach and modular analysis of their protein-coding gene association networks. |
Q36148711 | Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment |
Q33667686 | Current status and perspectives of patient-derived xenograft models in cancer research |
Q37361062 | LncRNA mediated regulation of aging pathways in Drosophila melanogaster during dietary restriction |
Q48159135 | Modeling phenotypes of malignant gliomas |
Q64244399 | Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches |
Q92922108 | Primary Tumor Site Specificity is Preserved in Patient-Derived Tumor Xenograft Models |
Q49319044 | Three-dimensional tumor model mimics stromal - breast cancer cells signaling. |
Q93006559 | Zebrafish Avatars towards Personalized Medicine-A Comparative Review between Avatar Models |
Search more.